212 related articles for article (PubMed ID: 37422913)
1. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
[TBL] [Abstract][Full Text] [Related]
2. Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
Rettig EM; Wang AA; Tran NA; Carey E; Dey T; Schoenfeld JD; Sehgal K; Guenette JP; Margalit DN; Sethi R; Uppaluri R; Tishler RB; Annino DJ; Goguen LA; Jo VY; Haddad RI; Hanna GJ
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1120-1130. PubMed ID: 36301568
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract][Full Text] [Related]
4. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
Berger BM; Hanna GJ; Posner MR; Genden EM; Lautersztain J; Naber SP; Del Vecchio Fitz C; Kuperwasser C
Clin Cancer Res; 2022 Oct; 28(19):4292-4301. PubMed ID: 35576437
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
6. Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
Hanna GJ; Roof SA; Jabalee J; Rettig EM; Ferrandino R; Chen S; Posner MR; Misiukiewicz KJ; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Gupta P; Kuperwasser C; Del Vecchio Fitz C; Berger BM
Clin Cancer Res; 2023 Oct; 29(20):4306-4313. PubMed ID: 37566241
[TBL] [Abstract][Full Text] [Related]
7. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsies with Circulating Plasma HPV-DNA Measurements-A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer.
Jakobsen KK; Bendtsen SK; Pallisgaard N; Friborg J; Lelkaitis G; Grønhøj C; von Buchwald C
Clin Cancer Res; 2023 Oct; 29(19):3914-3923. PubMed ID: 37477909
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.
Karp EE; Yin LX; O'Byrne TJ; Lu LY; Routman DM; Lester SC; Neben Wittich MA; Ma DJ; Price KA; Chintakuntlawar AV; Tasche KK; Price DL; Moore EJ; Van Abel KM
Laryngoscope; 2023 Jun; 133(6):1394-1401. PubMed ID: 35851669
[TBL] [Abstract][Full Text] [Related]
10. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
[TBL] [Abstract][Full Text] [Related]
11. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
[TBL] [Abstract][Full Text] [Related]
12. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
[TBL] [Abstract][Full Text] [Related]
13. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
14. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
[TBL] [Abstract][Full Text] [Related]
15. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
[TBL] [Abstract][Full Text] [Related]
16. Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma.
Reder H; Taferner VF; Wittekindt C; Bräuninger A; Speel EM; Gattenlöhner S; Wolf G; Klussmann JP; Wuerdemann N; Wagner S
J Mol Diagn; 2020 Nov; 22(11):1333-1343. PubMed ID: 32822851
[TBL] [Abstract][Full Text] [Related]
17. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
[TBL] [Abstract][Full Text] [Related]
18. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Chen KM; Stephen JK; Havard S; Mahan M; Divine G; Worsham MJ
JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):257-63. PubMed ID: 25569158
[TBL] [Abstract][Full Text] [Related]
19. Validation of the VisionArray® Chip Assay for HPV DNA Testing in Histology Specimens of Oropharyngeal Squamous Cell Carcinoma.
Channir HI; Bendtsen SK; Melchior LC; Sandholm PR; Mordhorst C; Carlander AF; von Buchwald C; Kiss K
Head Neck Pathol; 2024 Mar; 18(1):27. PubMed ID: 38536624
[TBL] [Abstract][Full Text] [Related]
20. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
